Skip to main content

A Humanized Preclinical in Vivo System to Predict the Immunotoxicity of Antibody Drug Candidates

James Keck, Ph.D., Senior Director of Innovation and Product Development, and Presidential Innovation Fellow, of The Jackson Laboratory speaks about a humanized preclinical in vivo system to predict the immunotoxicity of antibody drug candidates.